McKeough

Washington Trust Bancorp, Inc.'s Annual Meeting of Shareholders

Retrieved on: 
Thursday, April 27, 2023
Washington Trust Bank, Lead, WASH, Annual, Annual Meetings of the International Monetary Fund and the World Bank Group, Business, Meeting, State Street Corporation, Gender representation on corporate boards of directors, Corporation, McKeough, CPA, Bank, Management

WESTERLY, R.I., April 27, 2023 /PRNewswire/ -- Washington Trust Bancorp, Inc. (NASDAQ:  WASH; "Washington Trust" or "the Corporation"), the bank holding company for The Washington Trust Company, recently held its virtual Annual Meeting of Shareholders for the year ended December 31, 2022.

Key Points: 
  • WESTERLY, R.I., April 27, 2023 /PRNewswire/ -- Washington Trust Bancorp, Inc. (NASDAQ:  WASH; "Washington Trust" or "the Corporation"), the bank holding company for The Washington Trust Company, recently held its virtual Annual Meeting of Shareholders for the year ended December 31, 2022.
  • Handy III, Washington Trust Chairman and Chief Executive Officer, presided over the Meeting.
  • Gim who retired as President and Chief Operating Officer effective at the Annual Meeting.
  • As previously announced, Mary E. Noons has been appointed to succeed Gim as Washington Trust's President and Chief Operating Officer.

Recce Pharmaceuticals Appoints Alistair McKeough to its Board of Directors

Retrieved on: 
Wednesday, September 7, 2022
Professional services, Risk management, Human, Gram-negative bacteria, Safety, Recce, Infection, Virus, Culture, Pakistan Library Automation Group, Pew, Board, FSE, Synthetic, GLOBE, McKeough, Leadership, Board of directors, Company, FDA, RCE, ASX, GAIN, Degenerative disease, Acquisition, Growth, Bacteria, Organic, Audit, Vaccine, Pharmaceutical industry

SYDNEY, Australia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company) is pleased to announce the appointment of Alistair McKeough to its Board of Directors.

Key Points: 
  • SYDNEY, Australia, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company) is pleased to announce the appointment of Alistair McKeough to its Board of Directors.
  • The board and I are delighted to welcome Alistair as a non-executive director.
  • He knows the Company well, is excited about the future for Recce, and brings deep insights into Australias financial, corporate and regulatory environments.
  • On behalf of the board and shareholders, I welcome Alistair and Maggie and look forward to their contributions.